Therapy Areas: Allergy
Vedanta Biosciences Names Karuna Therapeutics CFO Ignelzi to Its Board of Directors
25 November 2020 - - US-based clinical-stage company Vedanta Biosciences has appointed Troy Ignelzi as an independent member of its board of directors, the company said.

Ignelzi has more ...
AbCellera's Bamlanivimab authorized to treat new mild to moderate COVID-19 in high-risk patients
23 November 2020 - Antibody discovery company AbCellera revealed on Friday that its human antibody bamlanivimab (LY-CoV555) in 700 mg, developed through its collaboration with Eli Lilly and Company, h...
AbCellera-Discovered Antibody Granted Interim Authorization by Health Canada as a Treatment for COVID-19
20 November 2020 - - Bamlanivimab (LY-CoV555) 700 mg, a human antibody developed through Canada-based AbCellera's collaboration with US-based Eli Lilly and Company (NYSE: LLY), was granted author...
Eli Lilly and Company & Incyte partnership announces FDA's EUA for use of baricitinib in combination with remdesivir in hospitalized adult and pediatric COVID-19 patients
20 November 2020 - Healthcare company Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ: INCY) on Thursday jointly announced the US Food and Drug Administration's (FDA) Emergency Use Authorizat...
Moderna Inc announces EMA's rolling review process of mRNA-1273 vaccine against COVID-19
18 November 2020 - Biotechnology company Moderna Inc (Nasdaq:MRNA) said on Tuesday that the European Medicines Agency (EMA) human medicines committee (CHMP) has started a rolling review of its vaccine...
Moderna Inks Supply Agreement with United Kingdom government to Supply mRNA Vaccine Against COVID-19 if Approved for Use
18 November 2020 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) has inked a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine c...
Related Headlines

Final Results from the Phase 3 HELP Study Open-Label Extension Support Takhzyro

Taiho, Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions

Medigen and BlueWillow Biologics Partner to Develop Intranasal Vaccine for SARS-CoV-2

Locus Biosciences and CARB-X to advance development of crPhage product targeting Klebsiella pneumoniae infections under USD14m precision medicine programme

AbCellera-Discovered Antibody Receives US FDA Emergency Use Authorization as a Monotherapy for the Treatment of COVID-19

Horizon Therapeutics Names Rosén as EVP of Research and Development, Chief Scientific Officer

OncoSec partners with Providence Cancer Institute to launch Phase 1 clinical trial of its CORVax12 vaccine candidate for COVID-19

POSTsilver's silver ion antibacterial film protects tough surfaces against viruses including COVID-19

Data for Lilly's Bamlanivimab in COVID-19 Outpatients Published in New England Journal of Medicine

First Patient Dosed in NIH ACTIV-5/Big Effect Trial Evaluating Lenzilumab for COVID-19

Biocom Purchasing Group Partners with Everlywell to Offer At-Home COVID-19 Testing and Lens Reporting Technology to Biocom Members

Lilly to stop an antibody treatment for hospitalised COVID-19 patients as results show it is of no help

FDA Approves First Treatment for COVID-19

US FDA Approves Gilead's Antiviral Veklury (remdesivir) for Treatment of COVID-19

The FDA approves Veklury (remdesivir) as first treatment for COVID-19 in patients 12 years of age and older